NRSN offering history
Every offering-related filing in NeuroSense Therapeutics Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 301 filings back to Aug 9, 2021.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 30, 2026 | F-3/A → | REGISTERED | F-3/A registration — capacity to sell shares, not a sale yet |
| Jan 29, 2026 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Nov 26, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 25, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 28, 2025 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Aug 18, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 18, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 8, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 16, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 16, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 21, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 17, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 16, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 26, 2024 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Dec 12, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 12, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 6, 2024 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Nov 22, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 22, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 19, 2024 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Oct 4, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 16, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 27, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 27, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 17, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 17, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 22, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 22, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 20, 2024 | F-1/A → | REGISTERED | F-1/A registration — capacity to sell shares, not a sale yet |
| May 10, 2024 | F-1 → | REGISTERED | F-1 registration — capacity to sell shares, not a sale yet |
| Apr 12, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 8, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 8, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 27, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 14, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 5, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 5, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 4, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 7, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Sep 5, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
NRSN offering FAQ
When did NRSN last execute an offering?
Per SEC filings, NeuroSense Therapeutics Ltd.'s most recent priced offering document is a 424B5 filed 2025-08-08. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did NRSN last announce or register an offering?
The most recent registration is a F-3/A filed 2026-07-30. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.